# Particular Ventures

Particular Ventures is a Venture Capital based in San Francisco, United States.

## Overview

- **Organization type:** Venture Capital
- **Headquarters:** San Francisco, United States
- **Region:** North America
- **Address:** San Francisco, CA, United States
- **Founded:** 2017
- **Assets under management:** Undisclosed
- **Website:** www.particularventures.com

## Regulatory record

- **Reports private funds:** No

## About

Particular Ventures invests in pre-seed and seed stage medical technology companies. Their focus includes medical devices, digital health, wearables, and consumerized healthcare. The firm has made 27 investments, including a seed investment in Ultralight on May 29, 2024.

## Sectors

- Medical Devices
- Digital Health
- Wearables
- Consumer Health

## Questions

### What investment stages does Particular Ventures target?

The firm writes pre-seed and seed-stage checks, which it describes as belief capital. It does not disclose check sizes or reserve allocation. Its public materials do not reference follow-on investing or later-stage participation.

### Which sectors does Particular Ventures explicitly avoid?

The investment thesis requires a consumer-facing medical device, wearable, or digital health product with a user experience element. Enterprise health IT, provider-focused software, therapeutics, diagnostics without a patient interface, and non-healthcare technology fall outside this mandate.

### How is Particular Ventures structured — is it a fund or an angel syndicate?

The firm styles itself as a closely held angel fund rather than an institutional venture vehicle. It does not disclose its legal structure, fund vehicles, or whether it operates as a general partnership, limited partnership, or single-investor entity.

### Has Particular Ventures produced liquidity for its investors?

The disclosed portfolio includes three acquisitions: Tueo Health (by Apple in 2018), Blumio (by CardieX in 2022), and Ultralight (by Greenlight Guru in 2025). Clover Health went public via SPAC in 2021. Several portfolio companies ceased operations between 2021 and 2025, including metaMe Health and TriVirum.

### Who makes investment decisions at Particular Ventures?

No investment professionals, investment committee members, or managing principals are named on the firm's website or in its public materials. The decision-making structure is not publicly disclosed.

## Related profiles

- [Particle Future](https://altss.com/profile/particle-future)
- [Partinc Capital](https://altss.com/profile/partinc-capital)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/particular-ventures

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology